● TIER 2 — Compoundable · emerging dataGRADE BAndrogens / AAS
Nandrolone & other AAS
AAS. Research verification: Yes (TGA pending). 2 human study record(s) in the FitClinicMD studies database.
GOALS · Muscle / body composition
FDA status
Nandrolone decanoate: approved ANDA history (anemia of CKD); US availability limited (not verified in this pass).
Compounding (503A/503B)
Status varies — see notes
DEA
DEA Schedule III.
WADA (sport)
S1 Anabolic agents
Mechanism
AR agonist (19-nortestosterone).
Human evidence · 2
AHA statement: cardiovascular toxicity of illicit AAS. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
HIV-associated weight loss RCT. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Reference only. This page summarizes publicly available regulatory and research information about Nandrolone & other AAS. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.